Biotech industry pe ratio
WebMarket Cap. €46.37m. PAIO.D key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA. Key Statistics. Enterprise Value/Revenue. 1.1x. Enterprise Value/EBITDA. 243.5x. WebDec 21, 2007 · Identical earnings growth rates of 10 percent are expected for each industry, with a price/earnings ratio of 16.7 for biotech and 14.1 for pharma. Baseline does not break out industry-wide stock ...
Biotech industry pe ratio
Did you know?
WebApr 11, 2024 · Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on. Vir Biotechnology Inc has a Value Score of 79, which is considered to be undervalued. Vir Biotechnology Inc’s price-earnings ratio is 6.2 compared to the industry median at 12.5. WebMarket Cap. JP¥98.22b. 4569 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA. Key Statistics. Enterprise Value/Revenue. 0.9x. Enterprise Value/EBITDA. 9.5x.
WebApr 10, 2024 · Current Industry PE. Investors are pessimistic on the American Biotechs industry, indicating that they anticipate long term growth rates will be lower than they … WebApr 11, 2024 · Current Industry PE. Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically. The 3-year average PS ratio of 9.0x is higher than …
WebThis page tells you which industry has the lowest valuation, highest dividend yield, highest opearting margins, highest ROE, etc. These are the median PE Ratio, Shiller PE Ratio, … WebApr 11, 2024 · Investors are optimistic on the American Life Sciences industry, and appear confident in long term growth rates. The industry is trading at a PE ratio of 66.7x which is higher than its 3-year average PE of 45.0x. The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 4.7x. Past Earnings Growth.
WebThe PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted).As of today (2024-03-24), Bio-Techne's share price is $72.54.Bio-Techne's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $1.61.Therefore, Bio-Techne's PE Ratio …
WebDetailed research and segmentation for the main products and markets. An assessment of the competitive landscape and market shares for major companies. And of course, much more. IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. notice boards for office makroWebApr 6, 2024 · The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether … notice boards for liftsWeb03/17 09:20. Investment Strategy. The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are ... notice boards for office for saleWebBiotechnology & Pharmaceuticals Industry's current Price to earnings ratio has decreased due to shareprice contraction of -4.13 %, from beginning of the and due to the sequtial … how to set working hours on googleWebThe basic materials sector includes companies that manufacture chemicals, building materials, and paper products. This sector also includes companies engaged in commodities exploration and processing. Companies in this sector include ArcelorMittal, BHP Billiton, and Rio Tinto. * Data in this page is the median value and it's updated daily. notice boards ebayWebP/E is short for the ratio of a company's share price to its per-share earnings. To calculate the P/E, you simply take the current stock price of a company and divide by its earnings … notice boards glassWebApr 6, 2024 · FA Report PDF. XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. XBI focuses on a narrow sector of the health care sector, and as such is probably too precise for most investors ... how to set working hours in outlook 365